创伤患者院前给予氨甲环酸:一项来自一级创伤中心的1:1匹配对比研究
本研究在一级创伤中心回顾性比较2017年1月至2018年9月接受或未接受院前氨甲环酸的成人创伤患者,未用氨甲环酸但入院4小时内输血者按年龄、性别、损伤严重度评分、头部简明损伤评分、院前心率和收缩压与用药组1:1匹配。共纳入204例(氨甲环酸组102例、对照组102例),平均年龄31岁。氨甲环酸组休克指数≥0.9的比值比为0.44(95%CI 0.23-0.84),对照组中位输血量更多(8单位 vs 3单位,P=0.01),大量输血比值比为0.35(95%CI 0.19-0.67);静脉血栓栓塞事件比值比2.0(95%CI 0.37-11.40),总死亡率比值比0.78(95%CI 0.42-1.45)未达统计学显著。作者结论认为院前氨甲环酸与更少输血和大量输血方案相关,血栓栓塞事件与死亡率无显著增加,但需更大规模临床试验进一步评估。
要点
- 氨甲环酸组休克指数≥0.9的比值比为0.44(95%CI 0.23-0.84),对照组入院时休克指数与乳酸更高(P=0.03、P=0.001)。
- 对照组中位输血量8单位(范围1-40)多于氨甲环酸组3单位(范围0-40),P=0.01。
- 大量输血方案的比值比为0.35(95%CI 0.19-0.67),氨甲环酸组使用更少。
- 静脉血栓栓塞事件氨甲环酸组比值比2.0(95%CI 0.37-11.40),总死亡率比值比0.78(95%CI 0.42-1.45),均未达统计学显著。
- 作者结论认为院前氨甲环酸与更少输血和大量输血方案相关,但需更大规模临床试验进一步评估。
适用人群与场景
- 2017年1月至2018年9月在一级创伤中心就诊的成人创伤患者,比较接受或未接受院前氨甲环酸者。
- 对照组为未接受氨甲环酸但入院4小时内输血的患者,按年龄、性别、损伤严重度评分、头部简明损伤评分、院前心率和收缩压与氨甲环酸组1:1匹配。
研究设计与关键结果
- 回顾性1:1匹配对比研究,共纳入204例成人创伤患者(氨甲环酸组102例、对照组102例),平均年龄31岁。
- 入院时对照组休克指数(P=0.03)和血清乳酸(P=0.001)高于氨甲环酸组,初始碱缺失、血红蛋白水平和EMS时间两组相当。
- 氨甲环酸组休克指数≥0.9的比值比为0.44(95%CI 0.23-0.84)。
- 对照组中位输血量8单位(范围1-40)多于氨甲环酸组3单位(范围0-40),P=0.01;大量输血方案比值比0.35(95%CI 0.19-0.67)。
- 氨甲环酸组静脉血栓栓塞事件比值比2.0(95%CI 0.37-11.40);总死亡率比值比0.78(95%CI 0.42-1.45),未达统计学显著。
证据类型、等级与局限
- 证据类型:回顾性1:1匹配对比研究。
- 局限:作者指出需更大规模临床试验进一步评估。
对床旁实践的改变
- 作者结论认为院前给予氨甲环酸与更少的院内输血和大量输血方案使用相关,血栓栓塞事件和死亡率无显著增加,但需更大规模临床试验进一步评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of this study was to test the efficacy of prehospital administration of tranexamic acid (TXA) to injured patients on mortality, thromboembolic events and need for blood transfusion in a level 1 trauma center.
METHODS: We conducted a retrospective study comparing adult trauma patients receiving or not receiving prehospital TXA between January 2017 and September 2018. Patients not receiving TXA but transfused within 4 h of admission were 1:1 matched to TXA-treated patients for age, sex, injury severity score, head abbreviated injury score, prehospital heart rate and systolic blood pressure.
RESULTS: In total 204 patients were included (102 TXA and 102 control), with a mean age of 31 years. On admission, shock index (p = 0.03) and serum lactate (p = 0.001) were greater in the control group, whereas the initial base deficit, hemoglobin levels and EMS time were comparable in both groups. The odd ratio (OR) for shock index ≥0.9 after TXA administration was 0.44 (95% CI 0.23-0.84). The median amount of blood transfusion was greater in the control group [eight units (range 1-40) vs three (range 0-40), p = 0.01] as well as the use of massive blood transfusion [OR 0.35 (95% CI 0.19-0.67)]. In the TXA group, VTE was higher [OR 2.0 (95% CI 0.37-11.40)]; whereas the overall mortality was lower [OR 0.78 (95% CI 0.42-1.45)] without reaching statistical significance.
CONCLUSIONS: Prehospital TXA administration is associated with less in-hospital blood transfusion and massive transfusion protocol (MTP). There is no significant increase in the thromboembolic events and mortality, however, further evaluation in larger clinical trials is needed.
参考来源
- El-Menyar A, Sathian B, Wahlen BM, et al. Prehospital administration of tranexamic acid in trauma patients: A 1:1 matched comparative study from a level 1 trauma center. Am J Emerg Med. 2019. PMID: 31060862. doi:10.1016/j.ajem.2019.04.051
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。